SR ONE CAPITAL MANAGEMENT, LLC sold ODTX

May 11, 2026 · Form 4 insider transaction

SR ONE CAPITAL MANAGEMENT, LLC sold 1,151,580 shares of Odyssey Therapeutics, Inc., a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Disposed (sell-side)
Shares
1,151,580
Price
N/A
Total value
N/A
Role10% owner
SecuritySeries A Convertible Preferred Stock
Transaction codeC: Conversion of a derivative
Transaction dateMay 11, 2026
Filing dateMay 11, 2026
Shares owned after0
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

The Series A Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration.; The securities are directly held by SR One Co-Invest IV, LLC ("SR One Co-Invest IV"). SR One Co-Invest IV Manager, LLC ("SR One Co-Invest Manager") is the managing member of SR One-Co-Invest IV, and SR One Capital Management is the managing member of SR One Co-Invest Manager. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Co-Invest Manager, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.

View the original Form 4 on SEC EDGAR